[go: up one dir, main page]

EP1732615A4 - PREPARATION OF PEPTIDES IN PLANTS AS VIRUS SHELL PROTEIN FUSION - Google Patents

PREPARATION OF PEPTIDES IN PLANTS AS VIRUS SHELL PROTEIN FUSION

Info

Publication number
EP1732615A4
EP1732615A4 EP05760992A EP05760992A EP1732615A4 EP 1732615 A4 EP1732615 A4 EP 1732615A4 EP 05760992 A EP05760992 A EP 05760992A EP 05760992 A EP05760992 A EP 05760992A EP 1732615 A4 EP1732615 A4 EP 1732615A4
Authority
EP
European Patent Office
Prior art keywords
peptides
plants
preparation
protein fusion
shell protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05760992A
Other languages
German (de)
French (fr)
Other versions
EP1732615A2 (en
Inventor
Kenneth E Palmer
Rachel L Toth
Mike Jones
Sean Chapman
Lisa Smolenska
Alison A Mccormick
Gregory P Pogue
Long V Nguyen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kentucky Bioprocessing LLC
Original Assignee
Kentucky Bioprocessing LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kentucky Bioprocessing LLC filed Critical Kentucky Bioprocessing LLC
Publication of EP1732615A2 publication Critical patent/EP1732615A2/en
Publication of EP1732615A4 publication Critical patent/EP1732615A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6075—Viral proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/12011—Bunyaviridae
    • C12N2760/12211—Phlebovirus, e.g. Rift Valley fever virus
    • C12N2760/12222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/14011—Filoviridae
    • C12N2760/14111—Ebolavirus, e.g. Zaire ebolavirus
    • C12N2760/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EP05760992A 2004-03-25 2005-03-25 PREPARATION OF PEPTIDES IN PLANTS AS VIRUS SHELL PROTEIN FUSION Withdrawn EP1732615A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55674604P 2004-03-25 2004-03-25
PCT/US2005/010192 WO2005108564A2 (en) 2004-03-25 2005-03-25 Production of peptides in plants as viral coat protein fusion

Publications (2)

Publication Number Publication Date
EP1732615A2 EP1732615A2 (en) 2006-12-20
EP1732615A4 true EP1732615A4 (en) 2009-09-16

Family

ID=35320800

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05760992A Withdrawn EP1732615A4 (en) 2004-03-25 2005-03-25 PREPARATION OF PEPTIDES IN PLANTS AS VIRUS SHELL PROTEIN FUSION

Country Status (2)

Country Link
EP (1) EP1732615A4 (en)
WO (1) WO2005108564A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101193653B (en) * 2005-02-01 2013-03-27 美国政府健康及人类服务部 Papillomavirus L2 N-terminal peptides for the induction of broadly cross-neutralizing antibodies
GB0605265D0 (en) * 2006-03-15 2006-04-26 London School Hygiene & Tropical Medicine Virus-like particles of rift valley fever virus

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001066778A2 (en) * 2000-03-08 2001-09-13 Large Scale Biology Corporation Production of foreign polypeptides in plants as viral coat protein fusions
WO2002000169A2 (en) * 2000-06-26 2002-01-03 The United States Of America, As Represented By The Secretary Of Agriculture Production of vaccines using transgenic plants
US20040033585A1 (en) * 2002-06-07 2004-02-19 Mccormick Alison A. Flexible vaccine assembly and vaccine delivery platform
WO2004032622A2 (en) * 2002-09-03 2004-04-22 Large Scale Biology Corporation Production of peptides in plants as viral coat protein fusions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9108386D0 (en) * 1991-04-19 1991-06-05 Agricultural Genetics Co Modified plant viruses as vectors

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001066778A2 (en) * 2000-03-08 2001-09-13 Large Scale Biology Corporation Production of foreign polypeptides in plants as viral coat protein fusions
WO2002000169A2 (en) * 2000-06-26 2002-01-03 The United States Of America, As Represented By The Secretary Of Agriculture Production of vaccines using transgenic plants
US20040033585A1 (en) * 2002-06-07 2004-02-19 Mccormick Alison A. Flexible vaccine assembly and vaccine delivery platform
WO2004032622A2 (en) * 2002-09-03 2004-04-22 Large Scale Biology Corporation Production of peptides in plants as viral coat protein fusions

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
EMBERS M E ET AL: "Differential antibody responses to a distinct region of human papillomavirus minor capsid proteins", VACCINE, ELSEVIER LTD, GB LNKD- DOI:10.1016/J.VACCINE.2003.08.037, vol. 22, no. 5-6, 26 January 2004 (2004-01-26), pages 670 - 680, XP004485198, ISSN: 0264-410X *
KAWANA K ET AL: "Nasal immunization of mice with peptide having a cross-neutralization epitope on minor capsid protein L2 of human papillomavirus type 16 elicit systemic and mucosal antibodies", VACCINE, ELSEVIER LTD, GB LNKD- DOI:10.1016/S0264-410X(00)00367-4, vol. 19, no. 11-12, 8 December 2001 (2001-12-08), pages 1496 - 1502, XP004313964, ISSN: 0264-410X *
KAWANA K ET AL: "Safety and immunogenicity of a peptide containing the cross-neutralization epitope of HPV16 L2 administered nasally in healthy volunteers", VACCINE, ELSEVIER LTD, GB LNKD- DOI:10.1016/S0264-410X(03)00454-7, vol. 21, no. 27-30, 1 October 2003 (2003-10-01), pages 4256 - 4260, XP004462827, ISSN: 0264-410X *
KAWANA KEI ET AL: "Common neutralization epitope in minor capsid protein L2 of human papillomavirus types 16 and 6", JOURNAL OF VIROLOGY, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 73, no. 7, 1 July 1999 (1999-07-01), pages 6188 - 6190, XP002205240, ISSN: 0022-538X *
KAWANA Y ET AL: "Human papillomavirus type 16 minor capsid protein l2 N-terminal region containing a common neutralization epitope binds to the cell surface and enters the cytoplasm", JOURNAL OF VIROLOGY, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US LNKD- DOI:10.1128/JVI.75.5.2331-2336.2001, vol. 75, no. 5, 1 March 2001 (2001-03-01), pages 2331 - 2336, XP002263699, ISSN: 0022-538X *

Also Published As

Publication number Publication date
EP1732615A2 (en) 2006-12-20
WO2005108564A2 (en) 2005-11-17
WO2005108564A3 (en) 2006-01-12

Similar Documents

Publication Publication Date Title
ATE446376T1 (en) PREPARATION OF A TNFR-IG FUSION PROTEIN
EP1732581A4 (en) POLYPEPTIDE TRANSDUCTION AND FUSOGENIC PEPTIDES
ATE480567T1 (en) HIGHLY CONCENTRATED ANTIBODIES AND PROTEIN FORMULATIONS
ATE411015T1 (en) USE OF 1-AMINOCYCLOHEXANE DERIVATIVES TO MODIFY DEPOSITION OF FIBRILLOGENES AS PEPTIDES IN AMYLOID PATHIES
EP1490094A4 (en) ANTIBODY FUSION PROTEINS: EFFECTIVE ADJUVANTIES IN PROTEIN VACCINATION
HK1139180A1 (en) Methods of producing peptides/proteins in plants and peptides/proteins produced thereby
DE602005025855D1 (en) MACROCYCLIC PEPTIDES WITH EFFECT TO THE HEPATITIS C VIRUS
DK1641823T3 (en) GLP-1 analog fusion proteins
ATE484524T1 (en) NEW TISSUE FACTOR-DIRECTED THROMBOMODULIN FUSION PROTEINS AS ANTICOAGULANTS
GB0718984D0 (en) Structure of the hepatitis C virus NS5A protein
DK1523558T3 (en) Preparation of peptides and proteins by accumulation in endoplasmic reticulum-derived plant protein bodies
DE60214680D1 (en) PREPARATION OF BLACK TEA
ATE455093T1 (en) PREPARATION OF PREGABALIN AND RELATED COMPOUNDS
ATE428727T1 (en) NEW PEPTIDES BINDING TO THE ERYTHROPOIETIN RECEPTOR
ATE414098T1 (en) MACROCYCLIC PEPTIDES WITH ANTI-HEPATITIS C VIRUS EFFECT
IS8308A (en) Amino acids with affinity for the a2o protein
DE602004030605D1 (en) PREPARATION OF TITANIUM OXIDE
DE602006006710D1 (en) PREPARATION OF POLYTRIMETHYLENETHERGLYCOL AND COPOLYMERS THEREOF
FR2870126B1 (en) RECOMBINANT LENTIVIRAL VECTOR FOR EXPRESSION OF FLAVIVIRIDAE PROTEIN AND ITS APPLICATIONS AS VACCINE
EP1800689A4 (en) LIQUID PREPARATION OF PHYSIOLOGICALLY ACTIVE PEPTIDE
DE602005025090D1 (en) METHODS OF INCREASING THE PROTEIN POLYETHYLENE GLYCOL (PEG) CONJUGATION
EP1732615A4 (en) PREPARATION OF PEPTIDES IN PLANTS AS VIRUS SHELL PROTEIN FUSION
ATE534666T1 (en) ANTIBODIES AGAINST HEPATITIS C VIRUS E1E2 COMPLEX AND PHARMACEUTICAL COMPOSITIONS
EP1931368A4 (en) ANTIFUNGAL PEPTIDES AND METHODS OF USE THEREOF
WO2006060728A3 (en) Methods and compositions involving lcrv proteins

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20061025

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: KENTUCKY BIOPROCESSING, LLC

A4 Supplementary search report drawn up and despatched

Effective date: 20090818

17Q First examination report despatched

Effective date: 20100428

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20101109